Hong Kong, China vs United Kingdom of Great Britain and Northern Ireland: Previously treated cases tested for RR-/MDR-TB

Hong Kong, China
87.0%
in 2024
United Kingdom of Great Britain and Northern Ireland
87.0%
in 2024
Hong Kong, China rank
92nd
United Kingdom of Great Britain and Northern Ireland rank
92nd

Previously treated cases tested for RR-/MDR-TB over time

  • Hong Kong, China
  • United Kingdom of Great Britain and Northern Ireland
20406080100200520142024

How they compare

Hong Kong, China currently reports 87.0% against 87.0% in United Kingdom of Great Britain and Northern Ireland, a difference of 0.0%.

The two have swapped places 6 times across 18 shared years of data; in 2005 it was United Kingdom of Great Britain and Northern Ireland ahead.

Hong Kong, China ranks 92nd and United Kingdom of Great Britain and Northern Ireland ranks 92nd of 180 countries.

Across the 3 decades both report, Hong Kong, China averaged higher in 2 and United Kingdom of Great Britain and Northern Ireland in 1.

Head to head by decade

Decade Hong Kong, China United Kingdom of Great Britain and Northern Ireland Difference Ahead
2000s 45.8% 51.8% 6.0% United Kingdom of Great Britain and Northern Ireland
2010s 59.6% 58.2% 1.3% Hong Kong, China
2020s 87.8% 76.4% 11.4% Hong Kong, China

Averages of every year both report within each decade.

Frequently asked questions

Which has higher previously treated cases tested for rr-/mdr-tb, Hong Kong, China or United Kingdom of Great Britain and Northern Ireland?
Hong Kong, China, at 87.0% against 87.0% in United Kingdom of Great Britain and Northern Ireland as of 2024.
What is the difference in previously treated cases tested for rr-/mdr-tb between Hong Kong, China and United Kingdom of Great Britain and Northern Ireland?
0.0%, with Hong Kong, China ahead.
How many years of comparable data are there for Hong Kong, China and United Kingdom of Great Britain and Northern Ireland?
18 years are reported by both, from 2005 to 2024.
How do Hong Kong, China and United Kingdom of Great Britain and Northern Ireland rank globally for previously treated cases tested for rr-/mdr-tb?
Hong Kong, China ranks 92nd and United Kingdom of Great Britain and Northern Ireland ranks 92nd of 180 countries.
Where does this data come from?
World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Hong Kong, China vs United Kingdom of Great Britain and Northern Ireland: Previously treated cases tested for RR-/MDR-TB. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 14 September 2026, from https://health.statizoid.com/compare/previously-treated-cases-tested-for-rr-mdr-tb-percent/hong-kong-sar-china/united-kingdom/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/compare/previously-treated-cases-tested-for-rr-mdr-tb-percent/hong-kong-sar-china/united-kingdom/">Hong Kong, China vs United Kingdom of Great Britain and Northern Ireland: Previously treated cases tested for RR-/MDR-TB</a> — Statizoid

About this data

Indicator
Previously treated cases tested for RR-/MDR-TB (%)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
193 places, 3,089 data points, 2005–2024
Last refreshed